Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1120 | 1135 | 1230 | 1329 | 1756 | 3281 |
Fund Return | 11.99% | 13.54% | 22.96% | 9.95% | 11.92% | 12.62% |
Place in category | 775 | 868 | 446 | 420 | 155 | 20 |
% in Category | 35 | 38 | 22 | 25 | 11 | 3 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.15B | 18.17 | 9.14 | 13.09 | ||
UBS CH Institutional Fund 2 EquiPAX | 4.19B | 16.91 | 7.54 | 10.23 | ||
UBS CH Vitainvest 50 World U | 4.38B | 2.45 | -0.62 | 2.66 | ||
UBS CH Institutional Fund 2 EquUSAA | 2.21B | 18.12 | 8.92 | 12.85 | ||
UBS CH Institutional Fund 2 EquiSCX | 2.21B | 11.77 | 0.06 | 7.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Institutional Fund 2 EquiP2X | 9.15B | 18.17 | 9.14 | 13.09 | ||
UBS CH Institutional Fund 2 EquUSAA | 2.21B | 18.12 | 8.92 | 12.85 | ||
Credit Suisse Institutional FundUSI | 1.96B | 10.38 | 10.60 | 12.69 | ||
Credit Suisse Institutional FundDA | 1.96B | 7.01 | 10.88 | 12.49 | ||
Aktien USA Passiv CHF A1 | 1.91B | 18.13 | 9.03 | 12.86 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Apple | US0378331005 | 6.72 | 184.57 | +1.00% | |
Microsoft | US5949181045 | 6.54 | 412.32 | +0.43% | |
NVIDIA | US67066G1040 | 3.55 | 887.47 | -1.84% | |
Amazon.com | US0231351067 | 3.36 | 189.50 | +0.80% | |
Meta Platforms | US30303M1027 | 2.02 | 475.42 | +0.60% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review